Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy.
Lu C, Everhart L, Tilan J, Kuo L, Sun CC, Munivenkatappa RB, Jönsson-Rylander AC, Sun J, Kuan-Celarier A, Li L, Abe K, Zukowska Z, Toretsky JA, Kitlinska J. Lu C, et al. Among authors: tilan j. Oncogene. 2010 Oct 14;29(41):5630-42. doi: 10.1038/onc.2010.301. Epub 2010 Aug 2. Oncogene. 2010. PMID: 20676138 Free PMC article.
Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance.
Czarnecka M, Trinh E, Lu C, Kuan-Celarier A, Galli S, Hong SH, Tilan JU, Talisman N, Izycka-Swieszewska E, Tsuei J, Yang C, Martin S, Horton M, Christian D, Everhart L, Maheswaran I, Kitlinska J. Czarnecka M, et al. Among authors: tilan ju. Oncogene. 2015 Jun 11;34(24):3131-43. doi: 10.1038/onc.2014.253. Epub 2014 Aug 18. Oncogene. 2015. PMID: 25132261 Free PMC article.
NPY and NPY receptors in vascular remodeling.
Abe K, Tilan JU, Zukowska Z. Abe K, et al. Curr Top Med Chem. 2007;7(17):1704-9. doi: 10.2174/156802607782340948. Curr Top Med Chem. 2007. PMID: 17979779 Review.
Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effects.
Tilan JU, Lu C, Galli S, Izycka-Swieszewska E, Earnest JP, Shabbir A, Everhart LM, Wang S, Martin S, Horton M, Mahajan A, Christian D, O'Neill A, Wang H, Zhuang T, Czarnecka M, Johnson MD, Toretsky JA, Kitlinska J. Tilan JU, et al. Oncotarget. 2013 Dec;4(12):2487-501. doi: 10.18632/oncotarget.1604. Oncotarget. 2013. PMID: 24318733 Free PMC article.
37 results